Invention Grant
- Patent Title: Anti-LAG-3 antibodies and uses thereof
-
Application No.: US16687387Application Date: 2019-11-18
-
Publication No.: US11414485B2Publication Date: 2022-08-16
- Inventor: Lei Fang , Zhengyi Wang , Bingshi Guo , Jingwu Zang , Wenqing Jiang , Yongqiang Wang
- Applicant: I-MAB Biopharma US Limited
- Applicant Address: US MD Gaithersburg
- Assignee: I-MAB Biopharma US Limited
- Current Assignee: I-MAB Biopharma US Limited
- Current Assignee Address: US MD Gaithersburg
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61P37/04 ; A61K35/17 ; A61K39/00
Abstract:
The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.
Public/Granted literature
- US20200071403A1 ANTI-LAG-3 ANTIBODIES AND USES THEREOF Public/Granted day:2020-03-05
Information query
